Press briefing on EU recommendation for COVID-19 Vaccine AstraZeneca
This virtual press briefing will discuss the outcome of the evaluation of COVID-19 Vaccine AstraZeneca by EMA’s human medicines committee (CHMP).
- Emer Cooke (EMA's Executive Director)
- Bruno Sepodes (CHMP Vice-chair)
- Sabine Straus (PRAC Chair)
- Marco Cavaleri (Head of Biological Health Threats and Vaccines Strategy).
Marie-Agnes Heine, EMA's Head of Communication, will moderate the press briefing.
The press briefing is held in English.